PSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
COMPASS Pathways, a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, welcomed the topline data shared today from an open-label study of psilocybin therapy for depression in cancer patients.
Within one week of a single administration of COMP360 psilocybin therapy, 50% of participants achieved remission in depression symptoms, which was sustained for the eight week follow-up period.
Read moreThis article proclaims that magic mushrooms may be the biggest advance in treating depression since Prozac. The research continues to impress!
Read moreHere’s the latest on how there is a shift in psychiatry toward a new way of thinking about depression, its causes, and therapies.
The profession’s long embrace of the “monoamine hypothesis” — the idea that depression primarily results from abnormal levels of neurotransmitter chemicals in the brain and that drugs can restore the proper balance — is giving way to a more complex understanding and alternative treatments, from ketamine to psychedelics to magnetic stimulation.
Read moreResearchers are looking at how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.
Read moreIn this interview, leading psychedelic researcher, Robin Carhart-Harris, speaks with a participant in a psilocybin for depression trial on the potential of psychedelics.
Read moreThis study reports that psilocybin provides long-term relief of cancer-related anxiety and depression.
Read moreThe antidepressant effects of the psychedelic brew known as ayahuasca appear to be related to anti-inflammatory activity, according to new research from scientists in Brazil.
Their findings, published in the Journal of Psychopharmacology, provide new insights into the biological mechanisms behind the observed antidepressant effects of the substance.
Read moreA study of 27 people found that a treatment featuring the hallucinogen psilocybin worked better than the usual antidepressant medications, a team reported Wednesday in the journal JAMA Psychiatry.
Read moreA study of 27 people found that a treatment featuring the hallucinogen psilocybin worked better than the usual antidepressant medications, a team reported Wednesday in the journal JAMA Psychiatry.
Read moreNew research shows that microdosing LSD elevates mood and cognition.
Read moreWondering what to do when the future feels hopeless? Humans like to feel optimistic about and in control of where their life is headed. The pandemic has made it very hard to feel that way.
Read more